Stocks in Focus

SAMKEE CORP. Rises for Two Consecutive Days on Expectations of Expanded Humanoid Robot Parts Business [Featured Stock]

[Edaily Reporter Shin Ha-yeon ] SAMKEE CORP.(122350)has hit the daily price limit for two consecutive days.
According to MP Doctor on the 3rd, as of 9:08 a.m. that day, SAMKEE CORP. was trading at 2,345 won, up 29.99% from the previous trading day. This marks the second consecutive trading day that the stock has hit the daily price limit, following the previous day.
This is believed to have stimulated investor sentiment after the company announced on the 2nd that it would expand its robot parts portfolio to include pelvic and lower-body structures, starting with the supply of upper-body frames to a global humanoid robot company.
The company plans to first focus on supplying the initial batch of the humanoid upper-body frame currently under development. It aims to secure quality and productivity based on its aluminum die-casting technology and production capabilities, and then transition to a mass production supply system following prototype evaluation.
Subsequently, it will expand its business scope to include pelvic and lower-body structures, as well as leg frames. These components serve as core structural elements that support the load of humanoid robots, requiring high strength, lightweight design, and durability simultaneously. The company plans to secure a competitive edge by utilizing precision high-vacuum casting technology.
Previously, SAMKEE CORP. hit the daily price limit for three consecutive SamIl trading days starting on the 24th of last month following news that it had been selected as a developer of humanoid frames for a global robotics company.

Economy

Corporation

IT·Science

Economy

Corporate Bond Market Struggling to Meet Repayment Obligations… Shinhan Securities and GS Entec Conduct Bookbuilding

Amid a continued trend of net redemptions—where redemptions exceed new issuances—in the corporate bond market, Shinhan Investment Securities and GS Entec are set to conduct bookbuilding this week for …
2026-07-05 08:00:06

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

"If You Don't Know, Just Ask"... Naver's AI Tab Aims to Stand Out with Search AI That Reduces Misinformation

Naver (NAVER(035420)) is expanding its search service into an agent-based service that bridges the gap from information discovery to action, spearheaded by its next-generation “AI Tab.” Rather than co…
2026-07-05 08:00:05